97 related articles for article (PubMed ID: 23529322)
1. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
2. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
3. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
5. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
6. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma.
Principi M; Scavo MP; Piscitelli D; Villanacci V; Lovero R; Losurdo G; Girardi B; Ierardi E; Di Leo A
Scand J Gastroenterol; 2015 Aug; 50(8):1002-10. PubMed ID: 25862314
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
8. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
10. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
12. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
13. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
14. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
[TBL] [Abstract][Full Text] [Related]
16. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
17. Dysplasia-like epithelial atypia in ischemic bowel disease.
Abraham SC; Taggart MW; Loftus EV; Wu TT
Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
[TBL] [Abstract][Full Text] [Related]
18. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
[TBL] [Abstract][Full Text] [Related]
19. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
